• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    93.84 Up 2.01(2.19%) Dec 19, 4:00PM EST
    |After Hours : 93.03 Down 0.81 (0.86%) Dec 19, 6:19PM EST
    Add to Portfolio
    Prev Close:91.83
    Open:92.44
    Bid:N/A
    Ask:94.15 x 100
    1y Target Est:102.47
    Beta:1.16
    Earnings Date:Feb 24 - Mar 2 (Est.)
    Day's Range:91.10 - 94.19
    52wk Range:55.04 - 96.36
    Volume:1,834,682
    Avg Vol (3m):1,205,310
    Market Cap:13.84B
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BMRN

    Comparison

    Symbol% ChgMkt Cap
    BMRNUp 2.19%13.84B
    FOLDUp 1.90%636.95M
    SHPGDown 1.88%42.45B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):20.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.05
    Quarterly EPS Est (Dec-14) :-0.60
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-3.57

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback